Conversion of the Taiwanese and Korean sales subsidiaries into joint ventures
First written in FY2025-H1. 1 of 2 entries say "Achieved", first in FY2025. Latest entry: FY2025.
0 other companies' latest entry also says "Achieved".
- FY2025AchievedAnnual report
「In connection with the share transfer dated 2 January 2025 under the agreement, the company was removed from the scope of consolidation and became an equity-method affiliate.」
The planned conversion of the Taiwan and South Korea sales subsidiaries into joint ventures with Restar was completed, and they changed from consolidated subsidiaries to equity-method affiliates. - FY2025-H1First statedAnnual report
「Pursuant to a resolution of the Board of Directors dated 25 September 2024, the company entered into a share transfer agreement and shareholders’ agreement for the purpose of converting Dexerials Taiwan Corporation and Dexerials Korea Corporation into joint ventures. In connection with the share transfers under the agreements, Dexerials Taiwan Corporation was scheduled to be removed from the company’s consolidated subsidiaries and become an equity-method affiliate on 1 January 2025, and Dexerials Korea Corporation on 2 January 2025.」
The company decided to reorganize its sales operations in cooperation with Restar by converting its Taiwan and South Korea sales subsidiaries into equity-method affiliates in January 2025.